ArticlebioRxiv : the preprint server for biology2025
Inference of VEGFR2 dimerization kinetics on the cell surface by integrating single-molecule imaging and mathematical modeling.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
6 authors.
Funding
Abstract
Inter-receptor interactions play a key role in receptor signaling, which is the first step in cell signaling in response to external stimuli. In the case of Vascular Endothelial Growth Factor Receptor 2 (VEGFR2), dimerization is necessary for activation. VEGFR2 undergoes reversible interactions also in the absence of ligand. For a quantitative understanding of transmembrane signal transduction, it is necessary to quantify the interaction kinetics of VEGFR2 on the cell surface. Live-cell single-molecule imaging (SMI) has the powerful ability to capture receptor interaction events in their native cellular environment with high spatiotemporal resolution. However, it reveals these interactions for only the labeled subset, which is a small fraction of the full population of receptors. We have previously shown that mathematical modeling, combined with SMI data, offers a route to compensate for this lost information and infer the population-level receptor interaction kinetics from SMI data. Here, we applied this approach to VEGFR2, both wildtype full length VEGFR2 (FLR2) and a truncated mutant consisting of its extracellular and transmembrane domains (ECTM), which has been shown to exhibit reduced homotypic interactions in the absence of ligand. We developed a stochastic mathematical model mimicking VEGFR2 diffusion and interactions and determined the unknown model parameters through a combination of direct experimental measurements and stochastic model calibration. We found that a model of dimerization was sufficient to describe VEGFR2 interactions in the absence of ligand. While ECTM was primarily monomeric, FLR2 exhibited a substantial fraction of dimers. Our inference revealed that the difference between FLR2 and ECTM was primarily in the dimer association rate constant, which was about an order of magnitude lower for ECTM than for FLR2. To our knowledge, this is the first time that the interaction kinetics of VEGFR2 have been calculated in live cells.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.